Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS) saw a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 425,000 shares, a decrease of 6.2% from the November 15th total of 453,200 shares. Based on an average trading volume of 121,500 shares, the days-to-cover ratio is presently 3.5 days.

Addus HomeCare Stock Performance

ADUS opened at $125.00 on Monday. The company has a fifty day moving average of $125.64 and a two-hundred day moving average of $124.55. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.12. The stock has a market capitalization of $2.27 billion, a price-to-earnings ratio of 28.60, a PEG ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million for the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the company earned $1.03 EPS. The firm’s revenue for the quarter was up 7.1% compared to the same quarter last year. On average, equities research analysts forecast that Addus HomeCare will post 4.59 earnings per share for the current year.

Insider Buying and Selling

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO R Dirk Allison sold 12,500 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at approximately $17,476,034.52. The trade was a 8.10 % decrease in their position. The disclosure for this sale can be found here. 4.60% of the stock is owned by insiders.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. UMB Bank n.a. boosted its position in Addus HomeCare by 64.2% during the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after acquiring an additional 88 shares during the last quarter. Quarry LP purchased a new stake in shares of Addus HomeCare in the third quarter valued at approximately $28,000. Quest Partners LLC purchased a new stake in shares of Addus HomeCare in the second quarter valued at approximately $31,000. Innealta Capital LLC purchased a new position in Addus HomeCare during the second quarter worth approximately $44,000. Finally, Farther Finance Advisors LLC boosted its stake in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after buying an additional 366 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the subject of several recent analyst reports. KeyCorp assumed coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They set an “overweight” rating and a $150.00 price objective for the company. Stephens upped their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a research report on Wednesday, November 6th. Macquarie restated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. Oppenheimer increased their price objective on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Addus HomeCare presently has a consensus rating of “Moderate Buy” and a consensus price target of $131.63.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.